In conclusion, these results indicated that these five risk genes (CD19, FGF2, MAP4K1, DCN and STAT6) were actually differentially expressed between normal kidney samples and ccRCC tumour samples. The gene discussed is FGF2; the disease is nonpapillary renal cell carcinoma.